Results from a phase 1 study of the anti-immunoglobulin-like transcript 4 (ILT4) monoclonal antibody MK-4830 plus pembrolizumab in patients with previously treated advanced solid tumors

被引：0
|
作者：
Siu, Lillian L.
Gil-Martin, Marta
Cho, Byoung Chul
Perets, Ruth
Hilton, John
Geva, Ravit
Lugowska, Iwona
Gutierrez, Martin
Bonomi, Marcelo
Dziadziuszko, Rafal
Rasco, Drew
Ben-Ami, Eytan
Rodriguez, Cristina P.
Siddiqi, Shabana
Myer, Nicole
Suttner, Leah
Wilson, Douglas
Akala, Ombololaji O.
de Miguel, Maria
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2024-CT104
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
CT104
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Lenvatinib plus pembrolizumab for patients with previously treated advanced ovarian cancer: Results from the phase 2 multicohort LEAP-005 study
    Gonzalez-Martin, Antonio
    Chung, Hyun Cheol
    Saada-Bouzid, Esma
    Yanez, Eduardo
    Senellart, Helene
    Cassier, Philippe A.
    Basu, Bristi
    Corr, Bradley R.
    Girda, Eugenia
    Dutcus, Corina
    Okpara, Chinyere E.
    Ghori, Razi
    Jin, Fan
    Groisberg, Roman
    Lwin, Zarnie
    GYNECOLOGIC ONCOLOGY, 2024, 186 : 182 - 190
  • [32] Phase 1 dose escalation study of FGFR4 inhibitor in combination with pembrolizumab in advanced solid tumors patients
    Xu, Jianming
    Cui, Jiuwei
    Jiang, Haiping
    Zeng, Yan
    Cong, Xiuyu
    CANCER MEDICINE, 2023, 12 (07): : 7762 - 7771
  • [33] PHASE 1/2A STUDY OF THE NOVEL NONFUCOSYLATED ANTI-CTLA-4 MONOCLONAL ANTIBODY BMS-986218 ± NIVOLUMAB IN ADVANCED SOLID TUMORS: PART 1 RESULTS
    Friedman, Claire
    Carvajal, Richard
    Davar, Diwakar
    Castanon, Eduardo
    Ascierto, Paolo
    Calvo, Emiliano
    O'Hara, Mark
    Powell, Steven
    Shapira-Frommer, Ronnie
    Garralda, Elena
    Renouf, Daniel John
    Perets, Ruth
    Yunan, Mona
    Ravindran, Palanikumar
    Hammell, Amy
    O'Brien, Shaun
    Xu, Ke
    Wilson, Nicholas
    Jhatakia, Amy
    Mukhopadhyay, Anandaroop
    Gutierrez, Martin
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A620 - A621
  • [34] LEAP-005: A Phase 2 Multicohort Study of Lenvatinib Plus Pembrolizumab in Patients With Previously Treated Selected Solid Tumors-Results From the Colorectal Cancer Cohort
    Bekaii-Saab, Tanios S.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2021, 19 (09) : 6 - 7
  • [35] LEAP-005: A phase II multicohort study of lenvatinib plus pembrolizumab in patients with previously treated selected solid tumors-Results from the colorectal cancer cohort
    Gomez-Roca, Carlos
    Yanez, Eduardo
    Im, Seock-Ah
    Alvarez, Eduardo Castanon
    Senellart, Helene
    Doherty, Mark
    Garcia-Corbacho, Javier
    Lopez, Juanita Suzanne
    Basu, Bristi
    Maurice-Dror, Corinne
    Gill, Sanjeev Singh
    Ghori, Razi
    Kubiak, Peter
    Jin, Fan
    Norwood, Kevin Glen
    Chung, Hyun Cheol
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (03)
  • [36] A phase 1 study of MSC-1, a humanized anti-LIF monoclonal antibody, in patients with advanced solid tumors.
    Hyman, David Michael
    Brana, Irene
    Spreafico, Anna
    Schram, Alison M.
    Pandya, Naimish B.
    Hoffman, Kimberly
    Hallet, Robin
    Giblin, Patricia
    Anido, Judit
    Ruano, Isabel Huber
    Wasserman, Robert
    Magram, Jeanne
    Siu, Lillian L.
    Tabernero, Josep
    Seoane, Joan
    Baselga, Jose
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [37] A phase 1 study of serplulimab, a novel humanized monoclonal anti-PD-1 antibody, in patients with advanced solid tumors.
    Ho, Ching-Liang
    Chao, Tsu-Yi
    Chang, Chia Lun
    Lin, Hsuan-Yu
    Yang, Futang
    Wang, Qingyu
    Zhu, Jun
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [38] Initial results of a phase 1b/2 study of ADG126 (a masked anti-CTLA-4 SAFEbody ®) in combination with pembrolizumab (an anti-PD-1 antibody) in patients with advanced/metastatic solid tumors
    Li, Daneng
    Sharma, Sunil
    She, Kristine
    Li, Wenda
    Li, Ai
    Zheng, Songmao
    Liu, Guizhong
    Ndukwo, Ogon
    Hu-Lowe, Dana
    Chisamore, Michael
    Luo, Peter
    Zha, Jiping
    Patel, Manish R.
    CANCER RESEARCH, 2023, 83 (08)
  • [39] LEAP-005: A phase 2 multicohort study of lenvatinib plus pembrolizumab in patients with previously treated selected solid tumors-Results from the gastric cancer cohort.
    Chung, Hyun Cheol Cheol
    Lwin, Zarnie
    Gomez-Roca, Carlos A.
    Longo, Federico
    Yanez, Eduardo
    Alvarez, Eduardo Castanon
    Graham, Donna M.
    Doherty, Mark
    Cassier, Philippe
    Lopez, Juanita Suzanne
    Basu, Bristi
    Hendifar, Andrew Eugene
    Maurice-Dror, Corinne
    Gill, Sanjeev Singh
    Ghori, Razi
    Kubiak, Peter
    Jin, Fan
    Norwood, Kevin Glen
    Saada-Bouzid, Esma
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [40] LEAP-005: A phase 2 multicohort study of lenvatinib plus pembrolizumab in patients with previously treated selected solid tumors-Results from the colorectal cancer cohort.
    Gomez-Roca, Carlos A.
    Yanez, Eduardo
    Im, Seock-Ah
    Castanon Alvarez, Eduardo
    Senellart, Helene
    Doherty, Mark
    Garcia-Corbacho, Javier
    Suzanne Lopez, Juanita
    Basu, Bristi
    Maurice-Dror, Corinne
    Gill, Sanjeev Singh
    Ghori, Razi
    Kubiak, Peter
    Jin, Fan
    Norwood, Kevin Glen
    Chung, Hyun Cheol Cheol
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
12345